Active Targeting Gold Nanoparticle for Chemotherapy Drug Delivery: A Review

Abstract

Objective Active targeting strategy in chemotherapy drug delivery aims to improve the therapeutic outcomes and minimise the side effects of chemotherapeutics. This review discusses utilising ligands attached to gold nanoparticles (AuNPs) along with several specific ligands attached to AuNPs for active targeting in chemotherapy drug delivery. Key finding Antibodies, peptides, vitamins, DNA, polysaccharides, aptamers, and hormones showed active-targeting abilities as ligands attached to AuNPs. Active-targeting AuNPs enhanced cellular uptake and cytotoxicity in a specific cancer cell in vitro while reducing tumor growth in vivo by improving the photothermal, photodynamic and chemotherapy effects. Active-targeting ligands increased the internalization of AuNPs loaded onto the specific tumour site and minimised the accumulation in the normal site. Conclusion AuNPs with active-targeting ligands such as antibodies, peptides, vitamins, DNA polysaccharides, aptamers, and hormones can improve the therapeutic outcomes of chemotherapeutics and can attenuate the toxicity effect in normal cells. For further research and development, researchers should be addressing AuNP characterization, drug–ligand disposition, active-targeting AuNP quantification, and target-AuNPs pertinence concerning the desired therapeutic outcomes.

The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy

“…Because of the increased permeability and retention effect, EGCG-nanogold conjugates can be accumulated in the tumor, potentially increasing bioavailability and bioactivity locally [105][106][107][108][109][110]. Polymers, active agents, molecules, and other targeting ligands, such as monoclonal antibodies or peptides, can all be linked to nanogold [111][112][113][114]. A multifunctional nanoplatform can be designed in a variety of ways.…”